Robert Gerstl

Array ( [id] => 5936731 [patent_doc_number] => 20020061915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy' [patent_app_type] => new [patent_app_number] => 09/842595 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16985 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061915.pdf [firstpage_image] =>[orig_patent_app_number] => 09842595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898931 [patent_doc_number] => 20010047096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Sufidomaidocarboxylic acids, method for production thereof, and use therefor' [patent_app_type] => new [patent_app_number] => 09/840402 [patent_app_country] => US [patent_app_date] => 2001-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9531 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20010047096.pdf [firstpage_image] =>[orig_patent_app_number] => 09840402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418516 [patent_doc_number] => 06521759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-18 [patent_title] => 'Aminothiazole inhibitors of cyclin dependent kinases' [patent_app_type] => B2 [patent_app_number] => 09/839751 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14766 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521759.pdf [firstpage_image] =>[orig_patent_app_number] => 09839751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551223 [patent_doc_number] => 06399659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-04 [patent_title] => 'Hydrazine oxoacetamide derivative and insecticide' [patent_app_type] => B2 [patent_app_number] => 09/837656 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8790 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399659.pdf [firstpage_image] =>[orig_patent_app_number] => 09837656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065801 [patent_doc_number] => 20010044538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'p38 MAP kinase inhibitors' [patent_app_type] => new [patent_app_number] => 09/839712 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23366 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044538.pdf [firstpage_image] =>[orig_patent_app_number] => 09839712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889326 [patent_doc_number] => 20020013354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'p38 map kinase inhibitors' [patent_app_type] => new [patent_app_number] => 09/839710 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24329 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013354.pdf [firstpage_image] =>[orig_patent_app_number] => 09839710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7015215 [patent_doc_number] => 20010051645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Thyroid receptor ligands' [patent_app_type] => new [patent_app_number] => 09/836765 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26737 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051645.pdf [firstpage_image] =>[orig_patent_app_number] => 09836765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312925 [patent_doc_number] => 06613912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Epothilons C and D, preparation and compositions' [patent_app_type] => B2 [patent_app_number] => 09/836134 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5900 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613912.pdf [firstpage_image] =>[orig_patent_app_number] => 09836134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033459 [patent_doc_number] => 20020019380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds' [patent_app_type] => new [patent_app_number] => 09/833827 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11382 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019380.pdf [firstpage_image] =>[orig_patent_app_number] => 09833827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189171 [patent_doc_number] => 06734200 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Heterocyclylaminomethyloxazolidinones as antibacterials' [patent_app_type] => B1 [patent_app_number] => 09/807113 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49471 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734200.pdf [firstpage_image] =>[orig_patent_app_number] => 09807113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905621 [patent_doc_number] => 20020142290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'NS5B HCV polymerase inhibitors' [patent_app_type] => new [patent_app_number] => 09/828270 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13509 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142290.pdf [firstpage_image] =>[orig_patent_app_number] => 09828270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7629722 [patent_doc_number] => 06818634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => '7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds' [patent_app_type] => B2 [patent_app_number] => 09/823884 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14683 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818634.pdf [firstpage_image] =>[orig_patent_app_number] => 09823884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1301269 [patent_doc_number] => 06624310 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Epothilone minor constituents' [patent_app_type] => B1 [patent_app_number] => 09/719932 [patent_app_country] => US [patent_app_date] => 2001-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12153 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624310.pdf [firstpage_image] =>[orig_patent_app_number] => 09719932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1578921 [patent_doc_number] => 06448293 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Diphenyl ether compounds useful in therapy' [patent_app_type] => B1 [patent_app_number] => 09/810378 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43823 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448293.pdf [firstpage_image] =>[orig_patent_app_number] => 09810378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327333 [patent_doc_number] => 06329409 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Amine derivatives and skin preparations for external use containing the same' [patent_app_type] => 1 [patent_app_number] => 9/786358 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8781 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329409.pdf [firstpage_image] =>[orig_patent_app_number] => 786358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409021 [patent_doc_number] => 06310005 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Isothiazole carboxylic acid amides' [patent_app_type] => 1 [patent_app_number] => 9/787056 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8012 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 610 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310005.pdf [firstpage_image] =>[orig_patent_app_number] => 787056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880485 [patent_doc_number] => 20010031772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals' [patent_app_type] => new [patent_app_number] => 09/799082 [patent_app_country] => US [patent_app_date] => 2001-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8688 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031772.pdf [firstpage_image] =>[orig_patent_app_number] => 09799082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636420 [patent_doc_number] => 06380238 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands' [patent_app_type] => B1 [patent_app_number] => 09/786154 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26640 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380238.pdf [firstpage_image] =>[orig_patent_app_number] => 09786154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436020 [patent_doc_number] => 06355663 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Substituted isoxazolylthiophene compounds' [patent_app_type] => B1 [patent_app_number] => 09/786119 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6276 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355663.pdf [firstpage_image] =>[orig_patent_app_number] => 09786119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528763 [patent_doc_number] => 06479667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-12 [patent_title] => 'Crystalline forms of antibiotic side chain intermediates' [patent_app_type] => B2 [patent_app_number] => 09/796006 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 927 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479667.pdf [firstpage_image] =>[orig_patent_app_number] => 09796006 [rel_patent_id] =>[rel_patent_doc_number] =>)